Clinical trials recruiting in Ithaca, New York

Phase breakdown

Conditions recruiting in Ithaca, New York

Recruiting trials in Ithaca, New York

• A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
  NCT03526835 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
  NCT06492616 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
  NCT06312137 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• The Precision Nutrition New York Study
  NCT06777498 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 50 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Ithaca, New York?

4 recruiting trials have at least one study site in Ithaca, New York.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.